| CULVER CITY, Calif.–(BUSINESS WIRE)–Jun. 1, 2016– NantHealth, Inc. (formerly known as Nant Health, LLC), a next-generation, evidence-based, personalized healthcare company, announced today the pricing of its initial public offering of 6,500,000 shares of its common stock at a price to the public of $14.00 per share (which reflects a 1-for-5 1/2 reverse stock split of NantHealth’s common stock effected in connection with the conversion of the company from a limited liability company to a corporation). The shares are expected to begin trading on The NASDAQ Global Select Market on June 2, 2016, under the symbol “NH”. In addition, NantHealth has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock.
Jefferies LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering, and First Analysis Securities Corporation, Canaccord Genuity Inc., and FBR Capital Markets & Co. are acting as co-managers. A registration statement relating to these securities has been filed with the Securities and Exchange Commissionand was declared effective on June 1, 2016. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering is being made only by means of a prospectus. A copy of the final prospectus related to the offering may be obtained, when available, from: Jefferies LLC, Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 547-6340 or by email at [email protected]; or Cowen and Company, LLC, c/o Broadridge Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (631) 274-2806 or by fax at (631) 254-7140. |
